Boundless Bio
despite advancements in precision medicine targeted therapies cancers with gene amplifications generally do not respond to lot | Boundless Bio
Company
Deck Type
IPO
Deck date
March 2024
Slide
11 of 51
Related slides by other companies
Investor Conference
January 2024
Mergers and Acquisitions
January 2021
Investor Presentation
July 2023
Investor Presentation
July 2022
Search Thousands of Presentations by World Leading Companies

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases
© 2021-2023 Slidebook.io